MYP_109401
Basic Information
Galsulfase
Therapeutic / Biomedical activity Enzyme replacement therapy
Standard
255 amino acids
C1298H1992N352O371S11
Standard
Sequence
SGAGASRPPHLVFLLADDLGWNDVGFHGSRIRTPHLDALAAGGVLLDNYYTQPLCTPSRSQLLTGRYQIRTGLQHQIIWPCQPSCVPLDEKLLPQLLKEAGYTTHMVGKWHLGMYRKECLPTRRGFDTYFGYLLGSEDYYSHERCTLIDALNVTRCALDFRDGEEVATGYKNMYSTNIFTKRAIALITNHPPEKPLFLYLALQSVHEPLQVPEEYLKPYDFIQDKNRHHYAGMVSLMDEAVGNVTAALKSSGLWN
Physicochemical Analysis
28816.55 Da
6.58
-1.62
-2.53
-0.0063
-0.30
0.61
0.04
45.83
86.08
0.1059
44350.00
44725.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0151541 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Enzyme
9606
Structure & Mods
linear multidomain protein biologic [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Enzyme replacement
9 (6 to 21) minduring the first wk of treatment, 26 (8 to 40) minby the 24th wk..